KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -33.3% | 20,286 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -79.3% | 20,286 | -3.3% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | -17.1% | 20,986 | -27.9% | 0.00% | -50.0% |
| Q4 2021 | $35,000 | -57.3% | 29,126 | -7.2% | 0.00% | -50.0% |
| Q3 2021 | $82,000 | -71.8% | 31,376 | -42.8% | 0.00% | -71.4% |
| Q2 2021 | $291,000 | -21.4% | 54,876 | +0.1% | 0.01% | -30.0% |
| Q1 2021 | $370,000 | +141.8% | 54,845 | +142.9% | 0.02% | +53.8% |
| Q4 2020 | $153,000 | -88.4% | 22,580 | -87.1% | 0.01% | -89.7% |
| Q3 2020 | $1,315,000 | +16.4% | 175,305 | +63.0% | 0.13% | +17.8% |
| Q2 2020 | $1,130,000 | +12.5% | 107,534 | -5.9% | 0.11% | -10.1% |
| Q1 2020 | $1,004,000 | +73.7% | 114,253 | -27.0% | 0.12% | +133.3% |
| Q4 2019 | $578,000 | +70.0% | 156,534 | +75.4% | 0.05% | +54.5% |
| Q3 2019 | $340,000 | +57.4% | 89,225 | +163.9% | 0.03% | +50.0% |
| Q2 2019 | $216,000 | -77.7% | 33,815 | -71.1% | 0.02% | -78.8% |
| Q1 2019 | $969,000 | +64.5% | 117,129 | -2.8% | 0.10% | +38.7% |
| Q4 2018 | $589,000 | -48.5% | 120,509 | +4.0% | 0.08% | -42.3% |
| Q3 2018 | $1,143,000 | +47.5% | 115,819 | +105.3% | 0.13% | +35.4% |
| Q2 2018 | $775,000 | +57.5% | 56,420 | +81.6% | 0.10% | +50.0% |
| Q1 2018 | $492,000 | -5.2% | 31,070 | +10.7% | 0.06% | +1.6% |
| Q4 2017 | $519,000 | – | 28,070 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |